Roche Holding AG (ROP1N)

Profile

https://www.roche.com

Roche Holding AG is a Swiss biopharmaceutical and diagnostics company headquartered in Basel, Switzerland. The company develops, manufactures, and markets innovative medicines and diagnostic solutions worldwide, with a strong focus on oncology therapies derived from its integration with Genentech. Its bestselling pharmaceutical products target cancer treatment, while the diagnostics division provides centralized and point-of-care testing, bolstered by technologies in cell analysis, gene expression, genome sequencing, and nucleic acid purification. Oncology accounts for a significant portion of pharmaceutical sales, complemented by products serving researchers and healthcare providers. Roche Holding AG operates across healthcare sectors, including drug manufacturing and medical diagnostics, offering tools that support clinical decisions and research advancements. Founded in 1896, it maintains a prominent role in the global biopharmaceutical market through its diverse portfolio of blockbuster therapies and diagnostic innovations.